CANY
MRTX

Caxton Associates (New York)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Caxton Associates (New York)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,694
Closed -$300K – 666
2021
Q3 		$300K Sell
1,694
-1,815
-52% -$321K 0.03% 288
2021
Q2 		$567K Buy
+3,509
New +$567K 0.06% 134